No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate Sensitive: A1 - Approval abiraterone acetate Sensitive : A1	abiraterone acetate Sensitive: A1 - Approval abiraterone acetate Sensitive : A1
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	abiraterone acetate Resistant: A2 - Guideline abiraterone acetate Resistant : A2	abiraterone acetate Resistant: A2 - Guideline abiraterone acetate Resistant : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + degarelix Sensitive: A2 - Guideline abiraterone acetate + degarelix Sensitive : A2	abiraterone acetate + degarelix Sensitive: A2 - Guideline abiraterone acetate + degarelix Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + triptorelin Sensitive: A2 - Guideline abiraterone acetate + triptorelin Sensitive : A2	abiraterone acetate + triptorelin Sensitive: A2 - Guideline abiraterone acetate + triptorelin Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + leuprolide acetate Sensitive: A2 - Guideline abiraterone acetate + leuprolide acetate Sensitive : A2	abiraterone acetate + leuprolide acetate Sensitive: A2 - Guideline abiraterone acetate + leuprolide acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + histrelin acetate Sensitive: A2 - Guideline abiraterone acetate + histrelin acetate Sensitive : A2	abiraterone acetate + histrelin acetate Sensitive: A2 - Guideline abiraterone acetate + histrelin acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + goserelin acetate Sensitive: A2 - Guideline abiraterone acetate + goserelin acetate Sensitive : A2	abiraterone acetate + goserelin acetate Sensitive: A2 - Guideline abiraterone acetate + goserelin acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + dexamethasone Sensitive: A2 - Guideline abiraterone acetate + dexamethasone Sensitive : A2	abiraterone acetate + dexamethasone Sensitive: A2 - Guideline abiraterone acetate + dexamethasone Sensitive : A2
AR amplification	Prostate Cancer	AR amplification	Prostate Cancer	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B
TP53 deletion	Prostate Cancer	TP53 deletion	Prostate Cancer	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B
RB1 deletion	Prostate Cancer	RB1 deletion	Prostate Cancer	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B
BRCA2 deletion	Prostate Cancer	BRCA2 deletion	Prostate Cancer	abiraterone acetate Sensitive: B - Late Trials abiraterone acetate Sensitive : B	abiraterone acetate Sensitive: B - Late Trials abiraterone acetate Sensitive : B
AKR1C3 expression	Prostate Cancer	AKR1C3 expression	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR expression + CYP17A1 expression	Prostate Cancer	AR expression + CYP17A1 expression	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
TSPYL1 P62S	Prostate Cancer	TSPYL1 P62S	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR-V7 positive	Renal Cell Carcinoma	AR-V7 positive	Renal Cell Carcinoma	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
YBX1 rs10493112	Prostate Cancer	YBX1 rs10493112	Prostate Cancer	abiraterone acetate Sensitive: C3 – Early Trials abiraterone acetate Sensitive : C3	abiraterone acetate Sensitive: C3 – Early Trials abiraterone acetate Sensitive : C3
TUBB3 overexpression	Prostate Cancer	TUBB3 overexpression	Prostate Cancer	abiraterone acetate Sensitive: C3 – Early Trials abiraterone acetate Sensitive : C3	abiraterone acetate Sensitive: C3 – Early Trials abiraterone acetate Sensitive : C3
AR L702H	Prostate Cancer	AR L702H	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR T878A	Prostate Cancer	AR T878A	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
TP53 mutation	Prostate Cancer	TP53 mutation	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
CDK12 mutation	Prostate Cancer	CDK12 mutation	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR splice variant 9	Prostate Cancer	AR splice variant 9	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
HRD	Prostate Cancer	HRD	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
RB1 mutation	Prostate Cancer	RB1 mutation	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR mutation	Prostate Cancer	AR mutation	Prostate Cancer	abiraterone acetate + RG7440 Resistant: C3 – Early Trials abiraterone acetate + RG7440 Resistant : C3	abiraterone acetate + RG7440 Resistant: C3 – Early Trials abiraterone acetate + RG7440 Resistant : C3
PTEN mutation	Prostate Cancer	PTEN mutation	Prostate Cancer	abiraterone acetate + RG7440 Resistant: C3 – Early Trials abiraterone acetate + RG7440 Resistant : C3	abiraterone acetate + RG7440 Resistant: C3 – Early Trials abiraterone acetate + RG7440 Resistant : C3
TP53 mutation	Prostate Cancer	TP53 mutation	Prostate Cancer	abiraterone acetate + RG7440 Resistant: C3 – Early Trials abiraterone acetate + RG7440 Resistant : C3	abiraterone acetate + RG7440 Resistant: C3 – Early Trials abiraterone acetate + RG7440 Resistant : C3
FOXA mutation	Prostate Cancer	FOXA mutation	Prostate Cancer	abiraterone acetate + RG7440 Resistant: C3 – Early Trials abiraterone acetate + RG7440 Resistant : C3	abiraterone acetate + RG7440 Resistant: C3 – Early Trials abiraterone acetate + RG7440 Resistant : C3
AR mutation	Prostate Cancer	AR mutation	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
CYB5A rs1790834	Prostate Cancer	CYB5A rs1790834	Prostate Cancer	abiraterone acetate Sensitive: C3 – Early Trials abiraterone acetate Sensitive : C3	abiraterone acetate Sensitive: C3 – Early Trials abiraterone acetate Sensitive : C3
DDR	Prostate Cancer	DDR	Prostate Cancer	abiraterone acetate + prednisone Resistant: C3 – Early Trials abiraterone acetate + prednisone Resistant : C3	abiraterone acetate + prednisone Resistant: C3 – Early Trials abiraterone acetate + prednisone Resistant : C3

abiraterone acetate

Associations
(59)

Associations
(59)

abiraterone acetate

Associations(59)

Associations(59)

Associations
(59)

Associations
(59)